Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Rossignol

Showing results (181-190 of 541) with videos related to

Pageof 55
Sort By:
American Journal of Nephrology|September 4, 2018
Patiromer to Enable Spironolactone Use in the Treatment of Patients with Resistant Hypertension and Chronic Kidney Disease: Rationale and Design of the AMBER StudyRajiv Agarwal, Patrick Rossignol, Dahlia Garza, et al.
Trials|July 3, 2020
The I-MICRO trial, Ilomedin for treatment of septic shock with persistent microperfusion defects: a double-blind, randomized controlled trial-study protocol for a randomized controlled trialMatthieu Legrand, Hafid Ait Oufella, Daniel De Backer, et al.
Journal of the American Heart Association|June 18, 2016
Intima-Media Thickness Is Linearly and Continuously Associated With Systolic Blood Pressure in a Population-Based Cohort (STANISLAS Cohort Study)João Pedro Ferreira, Nicolas Girerd, Erwan Bozec, et al.
Heart Failure Reviews|August 13, 2020
Bias in natriuretic peptide-guided heart failure trials: time to improve guideline adherence using alternative approachesSusan Stienen, Ankeet Bhatt, João Pedro Ferreira, et al.
Heart (British Cardiac Society)|July 11, 2025
Plasma myeloperoxidase and echocardiographic markers of impaired diastolic function in healthy individualsNelson Wang, Constance Xhaard, Guillaume Baudry, et al.
European Journal of Heart Failure|August 9, 2012
Statin therapy and clinical outcomes in myocardial infarction patients complicated by acute heart failure: insights from the EPHESUS trialDaniela Dobre, Patrick Rossignol, Jan Murin, et al.
Lancet (London, England)|September 20, 2019
Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trialRajiv Agarwal, Patrick Rossignol, Alain Romero, et al.
Trials|March 7, 2019
Impact of renin-angiotensin system inhibitors continuation versus discontinuation on outcome after major surgery: protocol of a multicenter randomized, controlled trial (STOP-or-NOT trial)Matthieu Legrand, Emmanuel Futier, Marc Leone, et al.
American Heart Journal|November 11, 2019
Income level and inequality as complement to geographical differences in cardiovascular trialsJoão Pedro Ferreira, Patrick Rossignol, Pooja Dewan, et al.
American Journal of Hypertension|February 13, 2019
Nondipping Pattern and Cardiovascular and Renal Damage in a Population-Based Study (The STANISLAS Cohort Study)Marilucy Lopez-Sublet, Nicolas Girerd, Erwan Bozec, et al.
Pageof 55

Showing results (181-190 of 541) with videos related to

Sort By:
Pageof 55
American Journal of Nephrology|September 4, 2018
Patiromer to Enable Spironolactone Use in the Treatment of Patients with Resistant Hypertension and Chronic Kidney Disease: Rationale and Design of the AMBER StudyRajiv Agarwal, Patrick Rossignol, Dahlia Garza, et al.
Trials|July 3, 2020
The I-MICRO trial, Ilomedin for treatment of septic shock with persistent microperfusion defects: a double-blind, randomized controlled trial-study protocol for a randomized controlled trialMatthieu Legrand, Hafid Ait Oufella, Daniel De Backer, et al.
Journal of the American Heart Association|June 18, 2016
Intima-Media Thickness Is Linearly and Continuously Associated With Systolic Blood Pressure in a Population-Based Cohort (STANISLAS Cohort Study)João Pedro Ferreira, Nicolas Girerd, Erwan Bozec, et al.
Heart Failure Reviews|August 13, 2020
Bias in natriuretic peptide-guided heart failure trials: time to improve guideline adherence using alternative approachesSusan Stienen, Ankeet Bhatt, João Pedro Ferreira, et al.
Heart (British Cardiac Society)|July 11, 2025
Plasma myeloperoxidase and echocardiographic markers of impaired diastolic function in healthy individualsNelson Wang, Constance Xhaard, Guillaume Baudry, et al.
European Journal of Heart Failure|August 9, 2012
Statin therapy and clinical outcomes in myocardial infarction patients complicated by acute heart failure: insights from the EPHESUS trialDaniela Dobre, Patrick Rossignol, Jan Murin, et al.
Lancet (London, England)|September 20, 2019
Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trialRajiv Agarwal, Patrick Rossignol, Alain Romero, et al.
Trials|March 7, 2019
Impact of renin-angiotensin system inhibitors continuation versus discontinuation on outcome after major surgery: protocol of a multicenter randomized, controlled trial (STOP-or-NOT trial)Matthieu Legrand, Emmanuel Futier, Marc Leone, et al.
American Heart Journal|November 11, 2019
Income level and inequality as complement to geographical differences in cardiovascular trialsJoão Pedro Ferreira, Patrick Rossignol, Pooja Dewan, et al.
American Journal of Hypertension|February 13, 2019
Nondipping Pattern and Cardiovascular and Renal Damage in a Population-Based Study (The STANISLAS Cohort Study)Marilucy Lopez-Sublet, Nicolas Girerd, Erwan Bozec, et al.
Pageof 55